Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 20 Dec 2017
At a glance
- Drugs Glimepiride (Primary) ; Insulin glargine (Primary) ; Liraglutide (Primary) ; Sitagliptin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms GRADE
- 31 Aug 2018 Biomarkers information updated
- 13 Dec 2017 Planned End Date changed from 1 Aug 2020 to 1 Jul 2021.
- 07 Jul 2017 Status changed from recruiting to active, no longer recruiting.